nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—CYP1A1—Dacarbazine—muscle cancer	0.157	0.185	CbGbCtD
Fluvastatin—UGT1A1—Etoposide—muscle cancer	0.151	0.178	CbGbCtD
Fluvastatin—SLCO1B3—Methotrexate—muscle cancer	0.119	0.14	CbGbCtD
Fluvastatin—CYP1A2—Dacarbazine—muscle cancer	0.0701	0.0825	CbGbCtD
Fluvastatin—SLCO1B1—Methotrexate—muscle cancer	0.0692	0.0814	CbGbCtD
Fluvastatin—CYP3A5—Vincristine—muscle cancer	0.0503	0.0592	CbGbCtD
Fluvastatin—CYP3A5—Etoposide—muscle cancer	0.0461	0.0542	CbGbCtD
Fluvastatin—CYP2C8—Etoposide—muscle cancer	0.0443	0.0521	CbGbCtD
Fluvastatin—CYP2B6—Doxorubicin—muscle cancer	0.0399	0.0469	CbGbCtD
Fluvastatin—CYP1A2—Etoposide—muscle cancer	0.0343	0.0403	CbGbCtD
Fluvastatin—CYP3A4—Vincristine—muscle cancer	0.0196	0.0231	CbGbCtD
Fluvastatin—CYP2D6—Doxorubicin—muscle cancer	0.0193	0.0227	CbGbCtD
Fluvastatin—CYP3A4—Etoposide—muscle cancer	0.018	0.0211	CbGbCtD
Fluvastatin—CYP3A4—Doxorubicin—muscle cancer	0.0123	0.0144	CbGbCtD
Fluvastatin—UGT2B7—renal system—muscle cancer	0.00059	0.0566	CbGeAlD
Fluvastatin—SLCO1B3—vagina—muscle cancer	0.000522	0.0502	CbGeAlD
Fluvastatin—Osteoarthritis—Methotrexate—muscle cancer	0.000505	0.00364	CcSEcCtD
Fluvastatin—Nervous system disorder—Vincristine—muscle cancer	0.000502	0.00361	CcSEcCtD
Fluvastatin—UGT1A1—renal system—muscle cancer	0.000501	0.0481	CbGeAlD
Fluvastatin—Thrombocytopenia—Vincristine—muscle cancer	0.000501	0.00361	CcSEcCtD
Fluvastatin—Photosensitivity—Doxorubicin—muscle cancer	0.000498	0.00359	CcSEcCtD
Fluvastatin—Decreased appetite—Dactinomycin—muscle cancer	0.000498	0.00359	CcSEcCtD
Fluvastatin—Dysgeusia—Etoposide—muscle cancer	0.000498	0.00358	CcSEcCtD
Fluvastatin—Hyperhidrosis—Vincristine—muscle cancer	0.000495	0.00356	CcSEcCtD
Fluvastatin—Fatigue—Dactinomycin—muscle cancer	0.000494	0.00356	CcSEcCtD
Fluvastatin—Back pain—Etoposide—muscle cancer	0.000492	0.00354	CcSEcCtD
Fluvastatin—Pain—Dactinomycin—muscle cancer	0.00049	0.00353	CcSEcCtD
Fluvastatin—Vascular purpura—Doxorubicin—muscle cancer	0.000489	0.00352	CcSEcCtD
Fluvastatin—Muscle spasms—Etoposide—muscle cancer	0.000489	0.00352	CcSEcCtD
Fluvastatin—Anorexia—Vincristine—muscle cancer	0.000488	0.00351	CcSEcCtD
Fluvastatin—Hepatic failure—Doxorubicin—muscle cancer	0.000487	0.00351	CcSEcCtD
Fluvastatin—Eczema—Doxorubicin—muscle cancer	0.000487	0.00351	CcSEcCtD
Fluvastatin—Renal failure acute—Doxorubicin—muscle cancer	0.000474	0.00341	CcSEcCtD
Fluvastatin—Feeling abnormal—Dactinomycin—muscle cancer	0.000472	0.0034	CcSEcCtD
Fluvastatin—Ill-defined disorder—Etoposide—muscle cancer	0.000472	0.00339	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000469	0.00337	CcSEcCtD
Fluvastatin—Hot flush—Doxorubicin—muscle cancer	0.000468	0.00337	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000466	0.00336	CcSEcCtD
Fluvastatin—Menopausal symptoms—Doxorubicin—muscle cancer	0.000464	0.00334	CcSEcCtD
Fluvastatin—Insomnia—Vincristine—muscle cancer	0.000463	0.00333	CcSEcCtD
Fluvastatin—Paraesthesia—Vincristine—muscle cancer	0.00046	0.00331	CcSEcCtD
Fluvastatin—Malaise—Etoposide—muscle cancer	0.000458	0.0033	CcSEcCtD
Fluvastatin—Dermatitis bullous—Doxorubicin—muscle cancer	0.000458	0.0033	CcSEcCtD
Fluvastatin—Breast disorder—Methotrexate—muscle cancer	0.000457	0.00329	CcSEcCtD
Fluvastatin—Vertigo—Etoposide—muscle cancer	0.000457	0.00329	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000455	0.00328	CcSEcCtD
Fluvastatin—Leukopenia—Etoposide—muscle cancer	0.000455	0.00328	CcSEcCtD
Fluvastatin—Purpura—Doxorubicin—muscle cancer	0.000454	0.00327	CcSEcCtD
Fluvastatin—Abdominal pain—Dactinomycin—muscle cancer	0.000453	0.00326	CcSEcCtD
Fluvastatin—Body temperature increased—Dactinomycin—muscle cancer	0.000453	0.00326	CcSEcCtD
Fluvastatin—HMGCR—smooth muscle tissue—muscle cancer	0.000452	0.0434	CbGeAlD
Fluvastatin—SLC15A1—renal system—muscle cancer	0.000451	0.0433	CbGeAlD
Fluvastatin—Loss of consciousness—Etoposide—muscle cancer	0.000447	0.00322	CcSEcCtD
Fluvastatin—Decreased appetite—Vincristine—muscle cancer	0.000445	0.0032	CcSEcCtD
Fluvastatin—Cough—Etoposide—muscle cancer	0.000443	0.00319	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Vincristine—muscle cancer	0.000442	0.00318	CcSEcCtD
Fluvastatin—Fatigue—Vincristine—muscle cancer	0.000441	0.00318	CcSEcCtD
Fluvastatin—Hypertension—Etoposide—muscle cancer	0.000439	0.00316	CcSEcCtD
Fluvastatin—Constipation—Vincristine—muscle cancer	0.000438	0.00315	CcSEcCtD
Fluvastatin—Pain—Vincristine—muscle cancer	0.000438	0.00315	CcSEcCtD
Fluvastatin—Pain in extremity—Doxorubicin—muscle cancer	0.000438	0.00315	CcSEcCtD
Fluvastatin—Osteoarthritis—Doxorubicin—muscle cancer	0.000438	0.00315	CcSEcCtD
Fluvastatin—HMGCR—renal system—muscle cancer	0.000435	0.0418	CbGeAlD
Fluvastatin—Chest pain—Etoposide—muscle cancer	0.000433	0.00311	CcSEcCtD
Fluvastatin—Eosinophilia—Methotrexate—muscle cancer	0.000433	0.00311	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00043	0.00309	CcSEcCtD
Fluvastatin—Pancreatitis—Methotrexate—muscle cancer	0.000428	0.00308	CcSEcCtD
Fluvastatin—Discomfort—Etoposide—muscle cancer	0.000427	0.00308	CcSEcCtD
Fluvastatin—Face oedema—Doxorubicin—muscle cancer	0.000423	0.00304	CcSEcCtD
Fluvastatin—Hypersensitivity—Dactinomycin—muscle cancer	0.000422	0.00304	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Vincristine—muscle cancer	0.000419	0.00301	CcSEcCtD
Fluvastatin—Confusional state—Etoposide—muscle cancer	0.000418	0.00301	CcSEcCtD
Fluvastatin—SLCO1B1—renal system—muscle cancer	0.000417	0.0401	CbGeAlD
Fluvastatin—Anaphylactic shock—Etoposide—muscle cancer	0.000415	0.00299	CcSEcCtD
Fluvastatin—Infection—Etoposide—muscle cancer	0.000412	0.00297	CcSEcCtD
Fluvastatin—Asthenia—Dactinomycin—muscle cancer	0.000411	0.00296	CcSEcCtD
Fluvastatin—Thrombocytopenia—Etoposide—muscle cancer	0.000406	0.00292	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000406	0.00292	CcSEcCtD
Fluvastatin—Abdominal pain—Vincristine—muscle cancer	0.000405	0.00291	CcSEcCtD
Fluvastatin—Body temperature increased—Vincristine—muscle cancer	0.000405	0.00291	CcSEcCtD
Fluvastatin—Skin disorder—Etoposide—muscle cancer	0.000403	0.0029	CcSEcCtD
Fluvastatin—Erectile dysfunction—Methotrexate—muscle cancer	0.000402	0.0029	CcSEcCtD
Fluvastatin—Hyperhidrosis—Etoposide—muscle cancer	0.000401	0.00289	CcSEcCtD
Fluvastatin—Abdominal pain upper—Doxorubicin—muscle cancer	0.0004	0.00288	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Methotrexate—muscle cancer	0.000399	0.00287	CcSEcCtD
Fluvastatin—Breast disorder—Doxorubicin—muscle cancer	0.000396	0.00285	CcSEcCtD
Fluvastatin—Anorexia—Etoposide—muscle cancer	0.000395	0.00285	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000394	0.00284	CcSEcCtD
Fluvastatin—Diarrhoea—Dactinomycin—muscle cancer	0.000392	0.00282	CcSEcCtD
Fluvastatin—Nasopharyngitis—Doxorubicin—muscle cancer	0.000391	0.00282	CcSEcCtD
Fluvastatin—HMGCR—cardiac atrium—muscle cancer	0.00039	0.0375	CbGeAlD
Fluvastatin—Infestation NOS—Methotrexate—muscle cancer	0.00039	0.0028	CcSEcCtD
Fluvastatin—Infestation—Methotrexate—muscle cancer	0.00039	0.0028	CcSEcCtD
Fluvastatin—Gastritis—Doxorubicin—muscle cancer	0.000387	0.00279	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000386	0.00278	CcSEcCtD
Fluvastatin—Muscular weakness—Doxorubicin—muscle cancer	0.000386	0.00278	CcSEcCtD
Fluvastatin—UGT2B7—testis—muscle cancer	0.000381	0.0366	CbGeAlD
Fluvastatin—Conjunctivitis—Methotrexate—muscle cancer	0.000379	0.00273	CcSEcCtD
Fluvastatin—Influenza—Doxorubicin—muscle cancer	0.000378	0.00272	CcSEcCtD
Fluvastatin—Hypersensitivity—Vincristine—muscle cancer	0.000377	0.00272	CcSEcCtD
Fluvastatin—Eosinophilia—Doxorubicin—muscle cancer	0.000375	0.0027	CcSEcCtD
Fluvastatin—Sweating—Methotrexate—muscle cancer	0.000373	0.00269	CcSEcCtD
Fluvastatin—Paraesthesia—Etoposide—muscle cancer	0.000372	0.00268	CcSEcCtD
Fluvastatin—Pancreatitis—Doxorubicin—muscle cancer	0.000371	0.00267	CcSEcCtD
Fluvastatin—Dyspnoea—Etoposide—muscle cancer	0.00037	0.00266	CcSEcCtD
Fluvastatin—SLCO2B1—renal system—muscle cancer	0.000369	0.0354	CbGeAlD
Fluvastatin—Hepatobiliary disease—Methotrexate—muscle cancer	0.000368	0.00265	CcSEcCtD
Fluvastatin—Asthenia—Vincristine—muscle cancer	0.000367	0.00264	CcSEcCtD
Fluvastatin—Vomiting—Dactinomycin—muscle cancer	0.000364	0.00262	CcSEcCtD
Fluvastatin—Bronchitis—Doxorubicin—muscle cancer	0.000364	0.00262	CcSEcCtD
Fluvastatin—Rash—Dactinomycin—muscle cancer	0.000361	0.0026	CcSEcCtD
Fluvastatin—Decreased appetite—Etoposide—muscle cancer	0.000361	0.0026	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Etoposide—muscle cancer	0.000358	0.00258	CcSEcCtD
Fluvastatin—Fatigue—Etoposide—muscle cancer	0.000358	0.00257	CcSEcCtD
Fluvastatin—Constipation—Etoposide—muscle cancer	0.000355	0.00255	CcSEcCtD
Fluvastatin—Pain—Etoposide—muscle cancer	0.000355	0.00255	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000352	0.00253	CcSEcCtD
Fluvastatin—Diarrhoea—Vincristine—muscle cancer	0.00035	0.00252	CcSEcCtD
Fluvastatin—Hepatitis—Methotrexate—muscle cancer	0.00035	0.00252	CcSEcCtD
Fluvastatin—Pharyngitis—Methotrexate—muscle cancer	0.000347	0.0025	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000345	0.00249	CcSEcCtD
Fluvastatin—Feeling abnormal—Etoposide—muscle cancer	0.000342	0.00246	CcSEcCtD
Fluvastatin—Nausea—Dactinomycin—muscle cancer	0.00034	0.00245	CcSEcCtD
Fluvastatin—HMGCR—tendon—muscle cancer	0.00034	0.0326	CbGeAlD
Fluvastatin—Gastrointestinal pain—Etoposide—muscle cancer	0.000339	0.00244	CcSEcCtD
Fluvastatin—Dizziness—Vincristine—muscle cancer	0.000339	0.00244	CcSEcCtD
Fluvastatin—Infestation—Doxorubicin—muscle cancer	0.000337	0.00243	CcSEcCtD
Fluvastatin—Infestation NOS—Doxorubicin—muscle cancer	0.000337	0.00243	CcSEcCtD
Fluvastatin—Visual impairment—Methotrexate—muscle cancer	0.000337	0.00243	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000334	0.00241	CcSEcCtD
Fluvastatin—Erythema multiforme—Methotrexate—muscle cancer	0.000331	0.00238	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000331	0.00238	CcSEcCtD
Fluvastatin—Urticaria—Etoposide—muscle cancer	0.000329	0.00237	CcSEcCtD
Fluvastatin—HMGCR—bone marrow—muscle cancer	0.000329	0.0316	CbGeAlD
Fluvastatin—Body temperature increased—Etoposide—muscle cancer	0.000328	0.00236	CcSEcCtD
Fluvastatin—Abdominal pain—Etoposide—muscle cancer	0.000328	0.00236	CcSEcCtD
Fluvastatin—Conjunctivitis—Doxorubicin—muscle cancer	0.000328	0.00236	CcSEcCtD
Fluvastatin—Urinary tract infection—Doxorubicin—muscle cancer	0.000328	0.00236	CcSEcCtD
Fluvastatin—SLC15A1—vagina—muscle cancer	0.000326	0.0313	CbGeAlD
Fluvastatin—Vomiting—Vincristine—muscle cancer	0.000326	0.00234	CcSEcCtD
Fluvastatin—Cardiac disorder—Methotrexate—muscle cancer	0.000325	0.00234	CcSEcCtD
Fluvastatin—Sweating—Doxorubicin—muscle cancer	0.000323	0.00233	CcSEcCtD
Fluvastatin—Rash—Vincristine—muscle cancer	0.000323	0.00232	CcSEcCtD
Fluvastatin—Dermatitis—Vincristine—muscle cancer	0.000323	0.00232	CcSEcCtD
Fluvastatin—Headache—Vincristine—muscle cancer	0.000321	0.00231	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000319	0.0023	CcSEcCtD
Fluvastatin—Angiopathy—Methotrexate—muscle cancer	0.000317	0.00228	CcSEcCtD
Fluvastatin—Sinusitis—Doxorubicin—muscle cancer	0.000316	0.00228	CcSEcCtD
Fluvastatin—Immune system disorder—Methotrexate—muscle cancer	0.000316	0.00227	CcSEcCtD
Fluvastatin—HMGCR—vagina—muscle cancer	0.000315	0.0303	CbGeAlD
Fluvastatin—Chills—Methotrexate—muscle cancer	0.000314	0.00226	CcSEcCtD
Fluvastatin—Alopecia—Methotrexate—muscle cancer	0.000309	0.00222	CcSEcCtD
Fluvastatin—Mental disorder—Methotrexate—muscle cancer	0.000306	0.00221	CcSEcCtD
Fluvastatin—Hypersensitivity—Etoposide—muscle cancer	0.000306	0.0022	CcSEcCtD
Fluvastatin—Erythema—Methotrexate—muscle cancer	0.000304	0.00219	CcSEcCtD
Fluvastatin—Nausea—Vincristine—muscle cancer	0.000304	0.00219	CcSEcCtD
Fluvastatin—Rhinitis—Doxorubicin—muscle cancer	0.000304	0.00219	CcSEcCtD
Fluvastatin—Hepatitis—Doxorubicin—muscle cancer	0.000303	0.00218	CcSEcCtD
Fluvastatin—Hypoaesthesia—Doxorubicin—muscle cancer	0.000301	0.00217	CcSEcCtD
Fluvastatin—Pharyngitis—Doxorubicin—muscle cancer	0.000301	0.00216	CcSEcCtD
Fluvastatin—Oedema peripheral—Doxorubicin—muscle cancer	0.000298	0.00215	CcSEcCtD
Fluvastatin—Dysgeusia—Methotrexate—muscle cancer	0.000298	0.00215	CcSEcCtD
Fluvastatin—Asthenia—Etoposide—muscle cancer	0.000298	0.00214	CcSEcCtD
Fluvastatin—Connective tissue disorder—Doxorubicin—muscle cancer	0.000298	0.00214	CcSEcCtD
Fluvastatin—Back pain—Methotrexate—muscle cancer	0.000294	0.00212	CcSEcCtD
Fluvastatin—Pruritus—Etoposide—muscle cancer	0.000293	0.00211	CcSEcCtD
Fluvastatin—Visual impairment—Doxorubicin—muscle cancer	0.000292	0.0021	CcSEcCtD
Fluvastatin—HMGCR—head—muscle cancer	0.000291	0.028	CbGeAlD
Fluvastatin—SLCO2B1—tendon—muscle cancer	0.000288	0.0277	CbGeAlD
Fluvastatin—Erythema multiforme—Doxorubicin—muscle cancer	0.000286	0.00206	CcSEcCtD
Fluvastatin—Diarrhoea—Etoposide—muscle cancer	0.000284	0.00204	CcSEcCtD
Fluvastatin—Ill-defined disorder—Methotrexate—muscle cancer	0.000282	0.00203	CcSEcCtD
Fluvastatin—HMGCR—testis—muscle cancer	0.000281	0.027	CbGeAlD
Fluvastatin—Cardiac disorder—Doxorubicin—muscle cancer	0.000281	0.00202	CcSEcCtD
Fluvastatin—Flushing—Doxorubicin—muscle cancer	0.000281	0.00202	CcSEcCtD
Fluvastatin—Angiopathy—Doxorubicin—muscle cancer	0.000275	0.00198	CcSEcCtD
Fluvastatin—Malaise—Methotrexate—muscle cancer	0.000275	0.00198	CcSEcCtD
Fluvastatin—Dizziness—Etoposide—muscle cancer	0.000274	0.00197	CcSEcCtD
Fluvastatin—Immune system disorder—Doxorubicin—muscle cancer	0.000274	0.00197	CcSEcCtD
Fluvastatin—Vertigo—Methotrexate—muscle cancer	0.000273	0.00197	CcSEcCtD
Fluvastatin—Leukopenia—Methotrexate—muscle cancer	0.000272	0.00196	CcSEcCtD
Fluvastatin—Chills—Doxorubicin—muscle cancer	0.000272	0.00196	CcSEcCtD
Fluvastatin—Arrhythmia—Doxorubicin—muscle cancer	0.00027	0.00195	CcSEcCtD
Fluvastatin—Alopecia—Doxorubicin—muscle cancer	0.000268	0.00193	CcSEcCtD
Fluvastatin—Cough—Methotrexate—muscle cancer	0.000266	0.00191	CcSEcCtD
Fluvastatin—Mental disorder—Doxorubicin—muscle cancer	0.000265	0.00191	CcSEcCtD
Fluvastatin—Vomiting—Etoposide—muscle cancer	0.000264	0.0019	CcSEcCtD
Fluvastatin—Erythema—Doxorubicin—muscle cancer	0.000264	0.0019	CcSEcCtD
Fluvastatin—Rash—Etoposide—muscle cancer	0.000262	0.00188	CcSEcCtD
Fluvastatin—Dermatitis—Etoposide—muscle cancer	0.000261	0.00188	CcSEcCtD
Fluvastatin—Headache—Etoposide—muscle cancer	0.00026	0.00187	CcSEcCtD
Fluvastatin—Flatulence—Doxorubicin—muscle cancer	0.00026	0.00187	CcSEcCtD
Fluvastatin—Chest pain—Methotrexate—muscle cancer	0.000259	0.00187	CcSEcCtD
Fluvastatin—Arthralgia—Methotrexate—muscle cancer	0.000259	0.00187	CcSEcCtD
Fluvastatin—Myalgia—Methotrexate—muscle cancer	0.000259	0.00187	CcSEcCtD
Fluvastatin—Dysgeusia—Doxorubicin—muscle cancer	0.000258	0.00186	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000257	0.00185	CcSEcCtD
Fluvastatin—Discomfort—Methotrexate—muscle cancer	0.000256	0.00184	CcSEcCtD
Fluvastatin—Back pain—Doxorubicin—muscle cancer	0.000255	0.00184	CcSEcCtD
Fluvastatin—Muscle spasms—Doxorubicin—muscle cancer	0.000253	0.00182	CcSEcCtD
Fluvastatin—Confusional state—Methotrexate—muscle cancer	0.000251	0.0018	CcSEcCtD
Fluvastatin—Anaphylactic shock—Methotrexate—muscle cancer	0.000248	0.00179	CcSEcCtD
Fluvastatin—SLCO2B1—head—muscle cancer	0.000247	0.0237	CbGeAlD
Fluvastatin—Infection—Methotrexate—muscle cancer	0.000247	0.00178	CcSEcCtD
Fluvastatin—Nausea—Etoposide—muscle cancer	0.000246	0.00177	CcSEcCtD
Fluvastatin—Ill-defined disorder—Doxorubicin—muscle cancer	0.000245	0.00176	CcSEcCtD
Fluvastatin—Nervous system disorder—Methotrexate—muscle cancer	0.000244	0.00175	CcSEcCtD
Fluvastatin—Thrombocytopenia—Methotrexate—muscle cancer	0.000243	0.00175	CcSEcCtD
Fluvastatin—Skin disorder—Methotrexate—muscle cancer	0.000241	0.00174	CcSEcCtD
Fluvastatin—Hyperhidrosis—Methotrexate—muscle cancer	0.00024	0.00173	CcSEcCtD
Fluvastatin—SLCO2B1—testis—muscle cancer	0.000238	0.0229	CbGeAlD
Fluvastatin—Malaise—Doxorubicin—muscle cancer	0.000238	0.00171	CcSEcCtD
Fluvastatin—CYP2C8—renal system—muscle cancer	0.000237	0.0228	CbGeAlD
Fluvastatin—Vertigo—Doxorubicin—muscle cancer	0.000237	0.0017	CcSEcCtD
Fluvastatin—Anorexia—Methotrexate—muscle cancer	0.000237	0.0017	CcSEcCtD
Fluvastatin—Syncope—Doxorubicin—muscle cancer	0.000236	0.0017	CcSEcCtD
Fluvastatin—Leukopenia—Doxorubicin—muscle cancer	0.000236	0.0017	CcSEcCtD
Fluvastatin—Loss of consciousness—Doxorubicin—muscle cancer	0.000232	0.00167	CcSEcCtD
Fluvastatin—Cough—Doxorubicin—muscle cancer	0.00023	0.00166	CcSEcCtD
Fluvastatin—Hypertension—Doxorubicin—muscle cancer	0.000228	0.00164	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000226	0.00163	CcSEcCtD
Fluvastatin—Insomnia—Methotrexate—muscle cancer	0.000225	0.00162	CcSEcCtD
Fluvastatin—Chest pain—Doxorubicin—muscle cancer	0.000224	0.00162	CcSEcCtD
Fluvastatin—Myalgia—Doxorubicin—muscle cancer	0.000224	0.00162	CcSEcCtD
Fluvastatin—Arthralgia—Doxorubicin—muscle cancer	0.000224	0.00162	CcSEcCtD
Fluvastatin—Anxiety—Doxorubicin—muscle cancer	0.000224	0.00161	CcSEcCtD
Fluvastatin—Paraesthesia—Methotrexate—muscle cancer	0.000223	0.00161	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000223	0.0016	CcSEcCtD
Fluvastatin—CYP1A2—renal system—muscle cancer	0.000222	0.0213	CbGeAlD
Fluvastatin—Discomfort—Doxorubicin—muscle cancer	0.000222	0.0016	CcSEcCtD
Fluvastatin—Dyspnoea—Methotrexate—muscle cancer	0.000221	0.00159	CcSEcCtD
Fluvastatin—CYP1A1—renal system—muscle cancer	0.000219	0.021	CbGeAlD
Fluvastatin—Dyspepsia—Methotrexate—muscle cancer	0.000219	0.00157	CcSEcCtD
Fluvastatin—Confusional state—Doxorubicin—muscle cancer	0.000217	0.00156	CcSEcCtD
Fluvastatin—Decreased appetite—Methotrexate—muscle cancer	0.000216	0.00155	CcSEcCtD
Fluvastatin—Anaphylactic shock—Doxorubicin—muscle cancer	0.000215	0.00155	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000214	0.00154	CcSEcCtD
Fluvastatin—Fatigue—Methotrexate—muscle cancer	0.000214	0.00154	CcSEcCtD
Fluvastatin—CYP3A5—renal system—muscle cancer	0.000214	0.0206	CbGeAlD
Fluvastatin—Infection—Doxorubicin—muscle cancer	0.000214	0.00154	CcSEcCtD
Fluvastatin—CYP2B6—renal system—muscle cancer	0.000213	0.0204	CbGeAlD
Fluvastatin—Pain—Methotrexate—muscle cancer	0.000212	0.00153	CcSEcCtD
Fluvastatin—Shock—Doxorubicin—muscle cancer	0.000212	0.00152	CcSEcCtD
Fluvastatin—Nervous system disorder—Doxorubicin—muscle cancer	0.000211	0.00152	CcSEcCtD
Fluvastatin—Thrombocytopenia—Doxorubicin—muscle cancer	0.000211	0.00152	CcSEcCtD
Fluvastatin—Skin disorder—Doxorubicin—muscle cancer	0.000209	0.0015	CcSEcCtD
Fluvastatin—Hyperhidrosis—Doxorubicin—muscle cancer	0.000208	0.0015	CcSEcCtD
Fluvastatin—Anorexia—Doxorubicin—muscle cancer	0.000205	0.00148	CcSEcCtD
Fluvastatin—Feeling abnormal—Methotrexate—muscle cancer	0.000205	0.00147	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000203	0.00146	CcSEcCtD
Fluvastatin—Urticaria—Methotrexate—muscle cancer	0.000197	0.00142	CcSEcCtD
Fluvastatin—CYP2C19—vagina—muscle cancer	0.000197	0.0189	CbGeAlD
Fluvastatin—Abdominal pain—Methotrexate—muscle cancer	0.000196	0.00141	CcSEcCtD
Fluvastatin—Body temperature increased—Methotrexate—muscle cancer	0.000196	0.00141	CcSEcCtD
Fluvastatin—CYP1A1—cardiac atrium—muscle cancer	0.000196	0.0188	CbGeAlD
Fluvastatin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000196	0.00141	CcSEcCtD
Fluvastatin—Insomnia—Doxorubicin—muscle cancer	0.000195	0.0014	CcSEcCtD
Fluvastatin—Paraesthesia—Doxorubicin—muscle cancer	0.000193	0.00139	CcSEcCtD
Fluvastatin—Dyspnoea—Doxorubicin—muscle cancer	0.000192	0.00138	CcSEcCtD
Fluvastatin—Dyspepsia—Doxorubicin—muscle cancer	0.000189	0.00136	CcSEcCtD
Fluvastatin—Decreased appetite—Doxorubicin—muscle cancer	0.000187	0.00135	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000186	0.00134	CcSEcCtD
Fluvastatin—Fatigue—Doxorubicin—muscle cancer	0.000185	0.00134	CcSEcCtD
Fluvastatin—Constipation—Doxorubicin—muscle cancer	0.000184	0.00132	CcSEcCtD
Fluvastatin—Pain—Doxorubicin—muscle cancer	0.000184	0.00132	CcSEcCtD
Fluvastatin—Hypersensitivity—Methotrexate—muscle cancer	0.000183	0.00132	CcSEcCtD
Fluvastatin—Asthenia—Methotrexate—muscle cancer	0.000178	0.00128	CcSEcCtD
Fluvastatin—Feeling abnormal—Doxorubicin—muscle cancer	0.000177	0.00128	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000176	0.00127	CcSEcCtD
Fluvastatin—Pruritus—Methotrexate—muscle cancer	0.000176	0.00127	CcSEcCtD
Fluvastatin—CYP2C8—vagina—muscle cancer	0.000172	0.0165	CbGeAlD
Fluvastatin—Urticaria—Doxorubicin—muscle cancer	0.000171	0.00123	CcSEcCtD
Fluvastatin—Body temperature increased—Doxorubicin—muscle cancer	0.00017	0.00122	CcSEcCtD
Fluvastatin—Abdominal pain—Doxorubicin—muscle cancer	0.00017	0.00122	CcSEcCtD
Fluvastatin—Diarrhoea—Methotrexate—muscle cancer	0.00017	0.00122	CcSEcCtD
Fluvastatin—Dizziness—Methotrexate—muscle cancer	0.000164	0.00118	CcSEcCtD
Fluvastatin—CYP3A4—renal system—muscle cancer	0.000161	0.0154	CbGeAlD
Fluvastatin—CYP1A1—vagina—muscle cancer	0.000159	0.0152	CbGeAlD
Fluvastatin—Hypersensitivity—Doxorubicin—muscle cancer	0.000158	0.00114	CcSEcCtD
Fluvastatin—CYP2D6—renal system—muscle cancer	0.000158	0.0152	CbGeAlD
Fluvastatin—Vomiting—Methotrexate—muscle cancer	0.000158	0.00114	CcSEcCtD
Fluvastatin—Rash—Methotrexate—muscle cancer	0.000157	0.00113	CcSEcCtD
Fluvastatin—Dermatitis—Methotrexate—muscle cancer	0.000157	0.00113	CcSEcCtD
Fluvastatin—Headache—Methotrexate—muscle cancer	0.000156	0.00112	CcSEcCtD
Fluvastatin—CYP3A5—vagina—muscle cancer	0.000155	0.0149	CbGeAlD
Fluvastatin—Asthenia—Doxorubicin—muscle cancer	0.000154	0.00111	CcSEcCtD
Fluvastatin—CYP2B6—vagina—muscle cancer	0.000154	0.0148	CbGeAlD
Fluvastatin—CYP2C8—testis—muscle cancer	0.000153	0.0147	CbGeAlD
Fluvastatin—Pruritus—Doxorubicin—muscle cancer	0.000152	0.0011	CcSEcCtD
Fluvastatin—Nausea—Methotrexate—muscle cancer	0.000148	0.00106	CcSEcCtD
Fluvastatin—Diarrhoea—Doxorubicin—muscle cancer	0.000147	0.00106	CcSEcCtD
Fluvastatin—CYP1A1—head—muscle cancer	0.000147	0.0141	CbGeAlD
Fluvastatin—CYP2B6—head—muscle cancer	0.000142	0.0137	CbGeAlD
Fluvastatin—Dizziness—Doxorubicin—muscle cancer	0.000142	0.00102	CcSEcCtD
Fluvastatin—CYP2B6—testis—muscle cancer	0.000138	0.0132	CbGeAlD
Fluvastatin—Vomiting—Doxorubicin—muscle cancer	0.000137	0.000985	CcSEcCtD
Fluvastatin—Rash—Doxorubicin—muscle cancer	0.000136	0.000977	CcSEcCtD
Fluvastatin—Dermatitis—Doxorubicin—muscle cancer	0.000136	0.000976	CcSEcCtD
Fluvastatin—Headache—Doxorubicin—muscle cancer	0.000135	0.00097	CcSEcCtD
Fluvastatin—Nausea—Doxorubicin—muscle cancer	0.000128	0.00092	CcSEcCtD
Fluvastatin—CYP2D6—head—muscle cancer	0.000106	0.0102	CbGeAlD
Fluvastatin—CYP2D6—testis—muscle cancer	0.000102	0.00981	CbGeAlD
